These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 1673284

  • 1. Dyslipidemic effects of cigarette smoking on beta-blocker-induced serum lipid changes in systemic hypertension.
    Vyssoulis GP, Karpanou EA, Pitsavos CE, Toutouza MA, Paleologos AA, Toutouzas PK.
    Am J Cardiol; 1991 May 01; 67(11):987-92. PubMed ID: 1673284
    [Abstract] [Full Text] [Related]

  • 2. Differentiation of beta-blocker effects on serum lipids and apolipoproteins in hypertensive patients with normolipidaemic or dyslipidaemic profiles.
    Vyssoulis GP, Karpanou EA, Pitsavos CE, Skoumas JN, Paleologos AA, Toutouzas PK.
    Eur Heart J; 1992 Nov 01; 13(11):1506-13. PubMed ID: 1361175
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Plasma lipids during chronic antihypertensive therapy with different beta-blockers.
    Fogari R, Zoppi A, Pasotti C, Poletti L, Tettamanti F, Malamani G, Corradi L.
    J Cardiovasc Pharmacol; 1989 Nov 01; 14 Suppl 7():S28-32. PubMed ID: 2481787
    [Abstract] [Full Text] [Related]

  • 5. Lipid effects of celiprolol, a new cardioselective beta-blocker, versus propranolol.
    Sirtori CR, Johnson B, Vaccarino V, Montanari G, Cremoncini M, Gianfranceschi G, Sirtori M, Dujovne CA.
    Clin Pharmacol Ther; 1989 Jun 01; 45(6):617-26. PubMed ID: 2567218
    [Abstract] [Full Text] [Related]

  • 6. Effects of beta-blockers on plasma lipids during antihypertensive therapy.
    Lehtonen A.
    J Cardiovasc Pharmacol; 1985 Jun 01; 7 Suppl 2():S110-4. PubMed ID: 2409357
    [Abstract] [Full Text] [Related]

  • 7. Beta-blocker effects on plasma lipids during prolonged treatment of hypertensive patients with hypercholesterolemia.
    Fogari R, Zoppi A, Corradi L, Preti P, Mugellini A, Lusardi P.
    J Cardiovasc Pharmacol; 1999 Apr 01; 33(4):534-9. PubMed ID: 10218722
    [Abstract] [Full Text] [Related]

  • 8. The effects of adrenergic blockade on lipoproteins using the rat as an experimental model.
    Balasubramaniam S, Simons LA, Hickie JB, Chang S.
    Artery; 1990 Apr 01; 17(2):60-70. PubMed ID: 1968740
    [Abstract] [Full Text] [Related]

  • 9. Effects of beta-blockers on the concentration and oxidizability of plasma lipids.
    Dimmitt SB, Williams PD, Croft KD, Beilin LJ.
    Clin Sci (Lond); 1998 Jun 01; 94(6):573-8. PubMed ID: 9854453
    [Abstract] [Full Text] [Related]

  • 10. Effects of pindolol on serum lipids, apolipoproteins, and lipoproteins in patients with mild to moderate essential hypertension.
    Sasaki J, Saku K, Ideishi M, Arakawa K, Kato Y, Kuwano E, So T.
    Clin Ther; 1989 Jun 01; 11(2):219-24. PubMed ID: 2736568
    [Abstract] [Full Text] [Related]

  • 11. Lipid profile improvement following celiprolol.
    Herrmann JM, von Heyman F, Freischütz G.
    J Int Med Res; 1988 Jun 01; 16 Suppl 1():39A-46A. PubMed ID: 2906016
    [Abstract] [Full Text] [Related]

  • 12. Effects of indapamide and various diuretics alone or combined with beta-blockers on serum lipoproteins.
    Weidmann P, Bianchetti MG, Mordasini R.
    Curr Med Res Opin; 1983 Jun 01; 8 Suppl 3():123-34. PubMed ID: 6137325
    [Abstract] [Full Text] [Related]

  • 13. High density-lipoprotein subfractions of patients using cardio-selective beta-blockers.
    Kuster GM, Amann FW, Neuenschwander C, Drexel H.
    Cardiovasc Drugs Ther; 2002 Mar 01; 16(2):127-31. PubMed ID: 12090905
    [Abstract] [Full Text] [Related]

  • 14. Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data.
    Craig WY, Palomaki GE, Haddow JE.
    BMJ; 1989 Mar 25; 298(6676):784-8. PubMed ID: 2496857
    [Abstract] [Full Text] [Related]

  • 15. Comparison of carvedilol and metoprolol on serum lipid concentration in diabetic hypertensive patients.
    Bell DS, Bakris GL, McGill JB.
    Diabetes Obes Metab; 2009 Mar 25; 11(3):234-8. PubMed ID: 18564334
    [Abstract] [Full Text] [Related]

  • 16. Effect of metoprolol and pindolol monotherapy on plasma lipid- and lipoprotein-cholesterol levels (including the HDL subclasses) in mild hypertensive males and females.
    Szollár LG, Mészáros I, Tornóci L, Rischák K, Molnár M, Mányai S.
    J Cardiovasc Pharmacol; 1990 Jun 25; 15(6):911-7. PubMed ID: 1694913
    [Abstract] [Full Text] [Related]

  • 17. The emerging problem of plasma lipid changes during antihypertensive therapy.
    Johnson BF.
    J Cardiovasc Pharmacol; 1982 Jun 25; 4 Suppl 2():S213-21. PubMed ID: 6177959
    [Abstract] [Full Text] [Related]

  • 18. The effects of cardioselective vasodilating beta-blockers on lipids.
    Hunninghake DB.
    Am Heart J; 1991 Mar 25; 121(3 Pt 2):1029-32. PubMed ID: 1671728
    [Abstract] [Full Text] [Related]

  • 19. Antihypertensive drugs and blood lipids: the Oslo study.
    Leren P, Eide I, Foss OP, Helgeland A, Hjermann I, Holme I, Kjeldsen SE, Lund-Larsen PG.
    J Cardiovasc Pharmacol; 1982 Mar 25; 4 Suppl 2():S222-4. PubMed ID: 6177960
    [Abstract] [Full Text] [Related]

  • 20. Short-term effects of beta-adrenoceptor blocking drugs with and without cardioselectivity and intrinsic sympathomimetic activity on lipoprotein metabolism in hypertriglyceridaemic patients and in normal men.
    Durrington PN, Brownlee WC, Large DM.
    Clin Sci (Lond); 1985 Dec 25; 69(6):713-9. PubMed ID: 2866062
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.